Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ryan K, Zomorrodi"'
Autor:
Shiva Arami, Nadera J. Sweiss, Rani Rahat, Christian Ascoli, Bianca Romay, Karol Palasiewicz, Shiva Shahrara, Ryan K Zomorrodi, Chandana Tetali, Michael V. Volin, Monica Guma, Luke A. J. O'Neill, Sadiq Umar
Publikováno v:
Cellular and Molecular Life Sciences. 78:7693-7707
Recent studies have shown the significance of metabolic reprogramming in immune and stromal cell function. Yet, the metabolic reconfiguration of RA macrophages (MΦs) is incompletely understood during active disease and in crosstalk with other cell t
Autor:
Azam Ahmed, Michael V. Volin, M. Asif Amin, Karol Palasiewicz, Chandana Tetali, Ryan K Zomorrodi, Hatem A Elshabrawy, Nadera J. Sweiss, Katrien Van Raemdonck, Sadiq Umar, Bianca Romay, Shiva Shahrara
Publikováno v:
Arthritis & Rheumatology. 73:2003-2014
OBJECTIVE In rheumatoid arthritis (RA), elevated serum interleukin-34 (IL-34) levels are linked with increased disease severity. IL-34 binds to 2 receptors, macrophage colony-stimulating factor receptor (M-CSFR) and syndecan 1, which are coexpressed
Autor:
Osama Alzoubi, Anja Meyer, Tanya Pulido Gonzalez, Adel C. Burgos, Nadera Sweiss, Ryan K. Zomorrodi, Shiva Shahrara
Publikováno v:
Clinical Immunology. 251:109635
Publikováno v:
European Journal of Immunology
The molecular mechanism of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Spike protein was characterized to identify novel therapies. The impact of tofacitinib, IL‐6R Ab, or TNFi therapy was determined on Spike protein or LPS/IFN
Autor:
Karol Palasiewicz, Imran Ahmad, Nadera J. Sweiss, Chandana Tetali, Michael V. Volin, Katrien Van Raemdonck, M. Asif Amin, Bianca Romay, Shiva Shahrara, Ryan K Zomorrodi, Sadiq Umar
Publikováno v:
Eur J Immunol
This study elucidates the mechanism of CCL25 and CCR9 in rheumatoid arthritis (RA). RA synovial fluid (SF) expresses elevated levels of CCL25 compared to OA SF and plasma from RA and normal. CCL25 was released into RA SF by fibroblasts (FLS) and macr
Autor:
Sadiq Umar, Karol Palasiewicz, Anja Meyer, Prabhakaran Kumar, Bellur S. Prabhakar, Michael V. Volin, Rani Rahat, Mina Al-Awqati, Huan J. Chang, Ryan K. Zomorrodi, Jalees Rehman, Shiva Shahrara
Publikováno v:
Cellular and Molecular Life Sciences. 79
Escalated innate immunity plays a critical role in SARS-CoV-2 pathology; however, the molecular mechanism is incompletely understood. Thus, we aim to characterize the molecular mechanism by which SARS-CoV-2 Spike protein advances human macrophage (M
Autor:
Katrien Van Raemdonck, Shiva Shahrara, Huan J Chang, Sadiq Umar, Anja Meyer, Ryan K Zomorrodi, Mina Al-Awqati, Michael V. Volin, Karol Palasiewicz
Publikováno v:
Immunol Cell Biol
The current study was designed to delineate the functional significance of CCL21 on metabolic reprogramming in experimental arthritis and rheumatoid arthritis (RA) differentiated macrophages (MΦs). To characterize the influence of CCL21 on immunomet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e63352b76a359e56c6ab08fb46456914
https://europepmc.org/articles/PMC8810694/
https://europepmc.org/articles/PMC8810694/
Autor:
Sadiq, Umar, Karol, Palasiewicz, Michael V, Volin, Bianca, Romay, Rani, Rahat, Chandana, Tetali, Shiva, Arami, Monica, Guma, Christian, Ascoli, Nadera, Sweiss, Ryan K, Zomorrodi, Luke A J, O'Neill, Shiva, Shahrara
Publikováno v:
Cellular and molecular life sciences : CMLS. 78(23)
Recent studies have shown the significance of metabolic reprogramming in immune and stromal cell function. Yet, the metabolic reconfiguration of RA macrophages (MΦs) is incompletely understood during active disease and in crosstalk with other cell t
Autor:
Imran Ahmad, Karol Palasiewicz, Bianca Romay, Shiva Shahrara, Katrien Van Raemdonck, Nadera J. Sweiss, Michael V. Volin, M. Asif Amin, Chandana Tetali, Ryan K Zomorrodi, Sadiq Umar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7546f386d3c667860f61ad6dc50ca4f
https://doi.org/10.1002/eji.202048681/v3/response1
https://doi.org/10.1002/eji.202048681/v3/response1